Ovary Part 7
In part 7 of our ovarian cancer series, we discuss surgical considerations in ovarian cancer, including patient and disease-specific factors that can influence surgical decision making, methods to predict optimal cytoreduction, and the utility of secondary cytoreduction.
Ovary Part 6
In part 6 of our ovarian cancer series, we discuss germ cell tumors and sex cord stromal tumors, including surgical decision-making and adjuvant treatment recommendations.
Ovary Part 5
In this episode, we will discuss the nuances of workup and management of less common epithelial ovarian cancers, including clear cell, endometrioid, mucinous, and low grade serous carcinomas, borderline tumors, and carcinosarcomas.
Ovary Part 4
This is the fourth of seven episodes covering ovarian cancer. In this episode, we discuss the management of recurrent, platinum-resistant epithelial ovarian cancer. Join us to explore the prognosis of PROC, recommendations for systemic chemotherapy, the role of bevacizumab, the updates to FDA approval for PARPi use, and options for targeted therapies.
Ovary Part 3
This is the third of seven episodes covering ovarian cancer. In this episode, we discuss the management of recurrent, platinum-sensitive epithelial ovarian cancer. Join us to learn how to detect recurrence, preferred systemic therapy regimens, and the use of targeted agents.
Ovary Part 2
This is the second of seven episodes covering ovarian cancer. In this episode, we discuss the management of advanced stage epithelial ovarian cancer. Join us to learn about the importance of optimal debulking, options for up-front treatment, the utility of bevacizumab, and the use of PARP inhibitors.
Ovary Part 1
This is the first of seven episodes covering ovarian cancer. In this episode, we discuss diagnosis and management of early stage epithelial ovarian cancer. Join us to learn about epidemiology, classification, diagnostic tools, surgery and staging, and adjuvant treatment of early EOC.